Nine Monkeypox Cases Confirmed in United States
FRIDAY, May 27, 2022 (HealthDay News) -- Nine cases of monkeypox had been confirmed in seven states as of Wednesday, and there are likely to be more cases as a worldwide outbreak continues, U.S. health officials say.
The nine cases of the disease, which does not occur naturally in the United States, were identified in Massachusetts, Florida, Utah, Washington, California, Virginia, and New York, according to the U.S. Centers for Disease Control and Prevention, CNN reported. While the case in Virginia involves a woman, most of the cases "are within gay [and] bisexual men and other men who have sex with men," CDC Director Rochelle Walensky, M.D., said on Thursday.
The approach to the situation needs to be "guided by science, not by stigma," Walensky emphasized, CNN reported. "While some groups may have a greater chance of exposure right now, infectious diseases do not care about state or international borders. They're not contained within social networks, and the risk of exposure is not limited to any one particular group," Walensky explained. "We shouldn't be surprised to see more cases."
The CDC is working to learn how each of the nine patients contracted the virus. Walensky said some have a recent history of international travel to places with active monkeypox outbreaks, but others do not, CNN reported.
The disease is not thought to be easily transmitted, and typically, people pick up monkeypox from an infected animal. When human-to-human transmission occurs, it is usually through close direct contact, such as contact with lesions on the skin or the inhalation of large respiratory droplets. The CDC has told doctors and the public to watch for symptoms of monkeypox, which can include fever, headache, muscle aches, swollen lymph nodes, and lesions or pustules and a rash on the body, including the palms of the hands and the soles of the feet.
There are vaccines for monkeypox and they will be sent where needed, according to Walensky. "One of these vaccines, with the trade name of Jynneos, is approved for the prevention of monkeypox disease in adults 18 years of age and older," Walensky said. "CDC has mechanisms in place to move these products around the country so that they can be used for prevention or treatment for people who may benefit, wherever they may be."
Related Posts
Low Rate of Serious Adverse Events Linked to Shoulder Surgery
THURSDAY, July 14, 2022 (HealthDay News) -- The risk for serious adverse events...
China afloja sus normas para viajar mientras levanta las restricciones por la COVID
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) -- China planifica reducir...
FDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
MONDAY, Jan. 23, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...
United States Exceeds Western Europe for Excess Deaths
THURSDAY, March 30, 2023 (HealthDay News) -- The United States had a marked...